The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

14 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Opioid receptor modulating oxabicyclo[2.2.2]octane morphinansBDB
Purdue Pharma
Substituted pyrazino[2,2-a]isoquinoline derivativesBDB
Hoffmann-La Roche
5-(N-fused tricyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replicationBDB
Viiv Healthcare UK (NO.5)
Protein kinase inhibitor containing pyrrolopyridazine derivativeBDB
The Asan Foundation
Macrocyclic compounds as IRAK1/4 inhibitors and uses thereofBDB
Merck Patent
Rho kinase inhibitorsBDB
Kadmon
Design and synthesis of novel and potent inhibitors of the type II transmembrane serine protease, matriptase, based upon the sunflower trypsin inhibitor-1.BDB
Georgetown University Medical Center
N-Acylthiadiazolines, a new class of liver X receptor agonists with selectivity for LXRbeta.BDB
Gnf
Structure-function relationship of the inhibition of the 3,5,3'-triiodothyronine binding to the alpha1- and beta1-thyroid hormone receptor by amiodarone analogs.BDB
University of Amsterdam
Discovery and SAR study of novel dihydroquinoline containing glucocorticoid receptor ligands.BDB
Boehringer Ingelheim Pharmaceuticals
X-Ray crystal structures of Candida albicans dihydrofolate reductase: high resolution ternary complexes in which the dihydronicotinamide moiety of NADPH is displaced by an inhibitor.BDB
Gsk
Structure-based inhibitor design for an enzyme that binds different steroids: a potent inhibitor for human type 5 17beta-hydroxysteroid dehydrogenase.BDB
Chul
2,6-Quinolinyl derivatives as potent VLA-4 antagonists.BDB
Ucb Pharma
Structural basis for the highly selective inhibition of MMP-13.BDB
Aventis Pharma Deutschland